infusion spring 2010 final

8/9/2019 Infusion Spring 2010 Final

1/9

President's Message

Inside this Issue

www.maabb.org

Spring 201

First, let me congratulate Darla Chambers, past president for a very successful annualmeeting in Annapolis, Maryland. She and the Board of Directors forged a collaborativeeffort with a local microbiology group and produced a stellar meeting. As for me, I am t2010/2011 President of MAABB. I have held multiple positions over the years in the organization: committee member, Maryland delegate, committee chair, Vice President.

My involvement with MAABB began not long after I started working in a local hospitalblood bank. Someone thought I had something to give the organization. Yet, over theyears I think I have gained just as much as I have given, if not more. The friendships,

both personal and professional, will last a lifetime. My time with MAABB is always wellspent and is one of the easiest ways to network with other blood bankers. One of my ftasks will be selecting the location for the Annual Meeting in the near future. The BoardDirectors and I will evaluate, based on member input and vendor feedback, the possibof continuing the collaboration. I appreciate your ideas and suggestions from the meeti

evaluations, and look forward to hearing of what you want and need from MAABB. Visit the MAABB website to for-ward your suggestions.

As we move into our new year, the MAABB Board will work diligently to identify ways to provide quality and afford-able education to meet your needs. As best you can, we hope you and your facilities will take advantage of the exent topics and speakers MAABB has to offer. This year we will offer a Webinar, a new medium for us. Use of thisdelivery method will bring the best right into your lab or home, wherever you access the web.

The biggest challenge for me this year is to continue to provide affordable educational experiences for all technologists, bench techs, specialists and supervisors. This will push MAABB to expand our delivery methodology and usetechnology to our and our members advantage.

Membership is an area of concern for all organizations, and MAABB is no exception. Members will continue to havaccess to the membership directory from the MAABB website. Dessert meetings, a more intimate setting for mem-bers to connect with one another and spend quality time with some of the best minds in our field, will be offered. Ifyou would like to host a Dessert Meeting at your facility, please contact us now, since we will be scheduling the Fameeting.

would like to thank everyone for your continued support and involvement with MAABB. We could not continue tosuccessful without you. I would like to welcome all of our new members and encourage your involvement in a committee such as Education, Annual Meeting Planning or Member Relations. I look forward to serving your needs as

President and planning another outstanding Annual Meeting for 2010!

nterest Article :Due Diligence for Biovigilance 2-4Editors Note 4Webinar Information 5

Member Spotlight 2010 Annual Meeting Wrap-Up 6-New Member Application


2/9

www.maabb.org

Interest Article

Due Diligence for BiovigilanceWendy M. Paul, MDAssociate Director, Transfusion MedicineChildrens National Medical Center

Washington, DCPick up any newspaper, tune in to any news program, or listen in on a conversation on the subway. The topic of ptient safety occupies air time and the minds of the public, and in the last decade has become a high-profile publichealth concern. Medical errors have been cited as being responsible for as many 44,000 98,000 preventabledeaths each year according to a report issued by the Institute of Medicine in 19991. Subsequently, the Patient Safand Quality Improvement Act of 2005 enacted legislation supporting the establishment of a network of patient safeorganizations and a national patient safety database2. The intent of the Act was to create a culture of quality im-provement through voluntary and confidential reporting of adverse events. Five years later the topic of biovigilanchas created a similar stir within the transfusion community. Many centers have limited understanding of how bioviance is applicable to their operations, what the requirements and responsibilities for participation are, and the scoof potential benefits. Has your transfusion service done due diligence with regard to comprehending the movementoward biovigilance?

What is Biovigilance?n the broad sense it is defined as watchfulness, attention, observation and awareness of outcomes resulting fromthe administration of biologics, which in our business includes drugs, blood and blood products, and tissues. In tcontext of patient safety initiatives, Biovigilance is one component of the National Healthcare Safety Network (NHSwhich is a secure internet-based surveillance system created by the Centers for Disease Control (CDC). The NHSs a four part system consisting of the following components: Patient Safety, Healthcare Personnel Safety, Biovigiance, and Research and Development. The NHSN allows facilities to collect and use data about healthcare-associated infections, multi-drug resistant organisms, personnel safety and vaccination trends, and adverse eventsrelated to transfusion of blood and blood products.

The Biovigilance Component was created at the recommendation of the Advisory Committee on Blood Safety andAvailability (ACBSA) of the Department of Health and Human Services (HHS), and developed in collaboration with

the transfusion and transplant communities. Specifically, the AABB initiated an inter-organizational Task Force onBiovigilance whose objective was the development of a comprehensive and integrated national patient safety pro-gram to collect, analyze, and report on the outcomes of collection and transfusion and/or transplantation of bloodcomponents and derivatives, tissues, organs, and cellular therapies3.

While biovigilance includes tissues, and organ transplantation as well as blood products, the Hemovigilance Moduwas the initial module developed for use, with additional modules anticipated in the future. National surveillance stems which report and monitor outcomes in transfusion recipients currently exist in most other developed countriespropelling the move to establish a similar system in the United States.

Why do we need a Hemovigilance Module?Data published in the 2007 National Blood Collection and Utilization Survey Report (NBCUS)4 showed that approxmately 14.6 million units of whole blood and red blood cells were collected in the United States in 2006, and trans-

fused to approximately 5 million recipients, averaging 1.5-3.0 units per recipient. The 2007 NBCUS also reported72,000 adverse events resulting in a rate of 0.32 %, which may represent underreporting in the United States, bason comparisons with surveillance systems in other countries with rates ranging from 0.3-0.7%3.

Continued on pag

EDITORS TRIVIA QUESTION

What is the blood donation process?


3/9

www.maabb.org

Interest Article Contd.

Despite the safety standards established by the Food and Drug Administra-tion (FDA) for facilities that collect, process and distribute blood (among themdonor screening, infectious disease testing, maintenance of deferred donorrecords, quarantine of all untested products, and donor eligibility verification),

the risk of non-infectious complications still exists, due to immune and physi-ologic mechanisms as well as systematic and/or human error. Capturing theoccurrence of adverse events in a standardized format should yield data thatwould provide early warning systems of safety issues, exchange of safetynformation and promote education and the application of evidence for prac-tice improvement.3

What does Hemovigilance mean for my facility?

There is currently no module available for blood collecting facilities; howeverbaseline data for severe adverse donor reactions was collected in the 2007NBCUS anticipating future development of a donor safety module.

According to the NHSN Biovigilance Component Protocol, surveillance

should be performed by hospital transfusion services and can be performedn any adult or pediatric acute or chronic care facility where transfusion oc-curs, including patient care areas for emergency, general medical, and surgi-cal patients; obstetrics and gynecology; orthopedics, oncology, and otherchronic diseases; and any other patient care setting where transfusion ser-vices are provided.3

The NHSN Biovigilance Component Manual is available at www.cdc.gov/nhsn/bio.html

The manual provides guidelines and procedures for monitoring hemovigilance. Specifically it provides standardizecase definition criteria for adverse events, including severity grades. It also outlines surveillance methods, detailsreporting requirements, and provides instruction for the completion of data collection forms using the NHSN web aplication. It should be noted that reporting adverse events to the NHSN does not replace current FDA reporting re

quirements.How do we get started?Before attempting to enroll directly through the NHSN website, contact the infection prevention team at your facilitydetermine if your facility is already a member of the NHSN. If so, you do not need to re-enroll to use the BiovigilanModule. A facility may utilize as many of the components as desired (with the exception of the Research and Devopment Component which involves internal CDC activities focused on enabling infection control software systems communicate directly with NHSN).

f your facility is enrolled in NHSN, your NHSN Facility Administrator must activate the Biovigilance Component.Once activated, the Administrator can designate a Biovigilance Component Primary Contact and add at least oneNHSN User with rights to the Biovigilance Component.

f your facility has not previously enrolled in NHSN, enrollment requirements and on-line training units can be found

at www.cdc.gov/nhsn/enroll.html

There is no cost to participating facilities, beyond the human resources and computer hardware required for the puposes of reporting.

AABB-CDC Sponsored Activities5The AABB Annual Meeting and CTTXPO October 9-12, 2010, in Baltimore, Maryland will offer a unique venue toearn more about the biovigilance movement. The following is a list of educational opportunities scheduled:

AABB Biovigilance Pavilion Biovigilance 101 Session Implementing Hemovigilance- Experience of Hospitals Large and Small

Continued on pg 4

Does your company nee

to target blood banking

and transfusion medicin

professionals?

Put your

ad here!

For advertising information

please contact Amie Eubankat [email protected]

or 859-264-7822


4/9

www.maabb.org

The majority of Blood Centers in the United States are operating with less than one day's supply of blood, accordinto the Association of Operating Room Nurses, Inc. This means catastrophe could possibly follow. We can categoria blood shortage as a disaster. We should have the same level of public support for blood shortage as we do for amother nature disaster. Patients who need blood in emergency situations absolutely depend on a readily availablesupply.

Washington, DC; Philadelphia; Baltimore have been hit hard by the blood shortage. With a limited blood supply, su

gical procedures, organ transplantation, and routine medical procedures become more dangerous. Reasons for th

blood shortage include a public misperception that enough blood is available. The current shortage is pushing the

system to its limits. The shortage is being credited to the increased demand for complex treatments such as organ

transplants, heart surgeries, and chemotherapy

Not many people realize that aggressive chem

therapy requires blood to replace damaged blo

cells. But the bottom line is that more individua

must now donate blood, it really comes down t

new donations.

To donate blood, one must be healthy, at leastyears old and weigh 110 pounds or more. Ap-

pointments can be scheduled. Call your blood

donor center near you and make an appointme

Everyone have a safe spring and summer.

Walter Cancel Jr.

Interest Article Contd.

CDC Biovigilance Booth CDC Hemovigilance Module Training Day, October 7, 2010 in Baltimore, Maryland (registration www.cdc.gov/

nhsn/bio/registration.html) AABB-CDC Ask the Biovigilance Experts Session

There are a vast number of resources available to support the transition of adverse event reporting activities from oocal systems to the national surveillance repository of the NHSN. The capability to track, trend and interpret thedata will improve the safety of the products we transfuse. As blood bankers and transfusion medicine specialists, due diligence required to create a culture of safety, should be our standard operating procedure.

References:1. Kohn, Linda T.; Corrigan, Janet M.; Donaldson, Molla S., eds (2000). To Err is HumanBuilding a Safer Health

System. Washington, D. C.: National Academies Press.2. PUBLIC LAW 10941JULY 29, 2005 PATIENT SAFETY AND QUALITY IMPROVEMENT ACT OF 2005.3. The National Healthcare Safety Network (NHSN) Manual, Biovigilance Component. Division of Healthcare Qu

ity Promotion National Center for Emerging and Zoonotic Infectious Diseases (proposed) Centers for DiseaseControl and Prevention Atlanta, GA, USA.

Available at www.cdc.gov/nhsn/bio.html

4. AABB Survey. The 2007 National Blood Collection and Utilization Survey Report. Available at http://www.hhs.gov/ophs/bloodsafety/2007nbcus_survey.pdf

5. Williams, Lamont. AABB Annual Meeting to Feature U. S. Biovigilance Network Activities. In: AABB News July2010 Vol. 12 No. 7. Bethesda, MD.

Editors Note


5/9

www.maabb.org

NEW MEMBERS!

Decole Russell, AS, MLT(ASCP)- WRAIR, Silver Spring, MDDaisy Martinez, MT(ASCP)- Civista Medical Center, La Plata, MD

Jill Dalrymple, MT, AMT- Civista Medical Center, La Plata, MDJeannette Duren, MT- Holy Cross Hospital, Silver Spring, MD

Veronica Freeman, BS- Howard University Hospital, Washington, DCTheresa Boyd, MD- Howard University Hospital, Washington, DC

Myong Nam, MD- Inova Fairfax Hospital, Falls Church, VA

Member Spotlight

MAABB would like to welcome Ruth Ross as the new Secretary for the Board of Directors.Ruth is currently working in the Blood Bank at the Naval Medical Center Portsmouth, Vir-ginia. Ruths responsibilities include acting as the functional System Administrator for theBlood Bank computer system as well as serving as the Supervisor of Quality Control which

ncludes oversight for all validations. Ruth is currently training on red blood cell deglyceroliza-tion procedures so that she can manage the training of all techs prior to their deployments onthe ships. Ruth also works closely with the Blood Bank Medical Director in the coordinationof continuing education for the anesthesia residents as they rotate through the Blood Bank.Ruth is an active AABB assessor and enjoys scrapbooking and traveling. She is scheduledto travel to the Republic of Malawi in August on a mission trip for her church. Ruth is a wel-come addition to the Board of Directors and we look forward to working with her in the coming year.

MAABB offers its first educational Webinar!

Title: Performing Effective Internal AssessmentsDate/Time: Thursday, September 16 12:00PM EDTAudience: Blood Bank Supervisors/Managers, QA Staff, Technologists

Objectives: Describe the rationale behind performing internal assessments Identify different approaches for performing internal assessments Develop strategies for managing the results of internal assessments

Description: Internal assessments are a requirement of all AABB Standards. This webina

will discuss strategies for performing internal assessments that are both effective and

meaningful to the organization.Level: Intermediate

Registration will open August 9 at www.maabb.org


6/9

www.maabb.org

2010 Annual Meeting


7/9

www.maabb.org

2010 Annual Meeting Wrap-Up

The first 2010 MAABB Annual Meeting and Maryland Clinical Microbi-ology Conference was a success!! For those members who attended, Ihope you were pleased with the outcome. We realize it was definitelya trial run and we have more details to work on before moving forwardnext year. The Anne Arundel Health Sciences Institute facilities wereexcellent and we received very positive comments from the attendees.The lecture topics were timely for both Blood Bank and Microbiologytracks. Although there were some last minute changes and cancella-tions of speakers and topics which sometimes cannot be avoided, the meeting was a success. The evaluations wpositive and many attendees expressed interest in a combined meeting for next year.

Throughout the planning year, the main concern of MAABB was to offer an Annual Meeting that would be affordaband that would allow the organization to stay within budget limits. We were successful accomplishing that goal thiyear and that will help us move forward financially. We were also pleased that we were sold out on exhibitor spacand many exhibitors expressed interest in coming back next year as well as having a combined meeting next yearThe board does realize we were limited on the amount of vendor space in the facility and will take that into considetion when planning for next year.

f you havent had a chance yet, please visit the website and view the Annual Meeting pictures. I would like to extmy appreciation to Janet Cass-Baxter and Dave Torpey who were instrumental in helping us bring the meeting to-gether. It was a huge undertaking to combine two annual meetings with historically different formats into one happmarriage!! Like any great relationship, there were challenges and compromises to be made. In the end, the collabration was a success. I think there is definite benefit for various organizations in the allied health fields to partner tgether for education!! It allows all organizations to be more efficient, cost-conscious and offer more of a variety ofeducation for attendees.

Last but not least, we appreciate all of our members who were able to attend the Annual Meeting this year and be-come a part of history. We continue to welcome your ideas for future meetings and encourage your involvement wcommittees!! We also review the annual meeting evaluations closely for comments and suggestions. In order forMAABB to continue successfully in the future, we need more involvement from new members. Please contact any

the board members listed on the website if you would like to become more involved with our committees!! would like to welcome Michele Hunt, the MAABB President who will successfully lead MAABB over the next yearMichele has many years experience as an educator and understands the educational needs of blood bankers!

Darla R. Chambers, MT(ASCP)SMAABB Past Presid

EDITORS TRIVIA ANSWER

Registration Process to be a Blood DonorHealth History, Mini Physical and qualification

Collection of the BloodRefreshments Available After Donating Blood

Being a Blood Donor - A Selfless Act


8/9

MAABB Officers and Delegates

OFFICERS

President

Michelle Hunt, [email protected]

Vice PresidentKathy Angel, [email protected]

President Elect

Kathleen Whitlock, [email protected]

Secretary

Ruth E. Ross, [email protected]

Treasurer

Patricia Schwaninger,[email protected]

Past PresidentDarla Chambers, [email protected]

DELEGATES

DelawareLeslie Allshouse, [email protected]

Jennifer Ingram,[email protected]

District of ColumbiaAl Langeberg, [email protected]

Wendy Paul, [email protected]

MarylandJanet Cass-Baxter,[email protected]

Judith Sullivan,[email protected]

Virginia

Patrick Francis,[email protected] A. Westerman,[email protected]

Our Mission

It is the goal of the MAABB to become the most effective state/regional association ofblood banks. This Association serves the Mid-Atlantic region for continuing professional

education in the medical, scientific, technical and administrative aspects of blood

banking and transfusion medicine.

INFUSION

Editor

Walter Cancel, [email protected]

PublisherStrategy Association & Event Management, [email protected]


9/9INFUSION (Spring 2010)

Name:_______________________________________________ Degree/Certification:___________(Last) (First) (MI)

Home Address:________________________________________________________________

City:__________________________ State:________ Zip Code:_______________

Work Institution:______________________________________________________________

Work Address:________________________________________________________________

_________________________________________________________________

City:__________________________ State:________ Zip Code:_______________

Home Phone:__________________________ Work Phone:________________________

Mobile Phone:_________________________ Fax:________________________________

Email:________________________________________________________________________Please provide at least one email address (no more than two) as news of upcoming MAABB events and our Infusion newsletter is now sent via email.

Preferred Mailing Address: Home Work

MAABB Committees:Committee descriptions are found on the MAABB website: www.maabb.orgPlease check the committee(s)/subcommittee(s) on which you are currently serving or are interested in joining:

Member Relations Education Annual Meeting

Webpage DonorOperations Workshops Infusion Technical Workshops (TWC) SeminarProgram

Public Relations Training, RegulatoryAdministrative, Quality (TRAQ)

Would you be willing to participate in our workshops as a speaker or instructor? YesNoWould you be willing to serve as a district/state delegate? Yes No

Membership Category: Individual ($35.00 per annum) Sustaining ($65.00 per annum)

Make check payable to MAABB.Please return this form with your payment to: MAABBP.O. Box 9374

Silver Spring, MD 20916-9374

Membership Application(Please type or print clearly)

MAABB use only:Member ID:_________ MAABB membership application version 3 (12.09)

infusion spring 2010 final

Documents